Accelerate Diagnostics reported -19368000 in EBITDA for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Abbott ABT:US $ 3042M 769M
Becton, Dickinson and BDX:US $ 1094M 316M
Bio Rad Laboratories BIO:US $ 159.37M 49.79M
Bruker BRKR:US $ 111.2M 4.2M
Danaher DHR:US $ 1863M 667M
Genmark Diagnostics GNMK:US $ -0.46M 1.15M
Hologic HOLX:US $ 463.4M 415.5M
Illumina ILMN:US $ 236M 5M
Luminex LMNX:US $ 21.3M 3.09M
Meridian Bioscience VIVO:US $ 20.16M 18.77M
Myriad Genetics MYGN:US $ -2.1M 26.2M
Nanostring Technologies NSTG:US $ -24.2M 0.23M
Oxford Immunotec Global OXFD:US $ 0.79M 10.16M
Perkinelmer PKI:US $ 398.96M 158.86M
Quidel QDEL:US $ 38.82M 198.8M
Thermo Fisher Scientific TMO:US $ 2942M 766M